We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$915M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$161M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$78.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$56.9M |
| 5 |
AstraZeneca
AZN
|
+$53.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$170M |
| 2 |
AT&T
T
|
+$142M |
| 3 |
Microsoft
MSFT
|
+$136M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Schrodinger
SDGR
$1.12B
| $290K | ﹤0.01% |
8,494
-1,397
| -14% | -$42.4K |
|
1652
Coherus Oncology
CHRS
$217M
| $289K | ﹤0.01% |
22,408
-4,602
| -17% | -$58.5K |
|
1653
White Mountains Insurance
WTM
$5.47B
| $289K | ﹤0.01% |
254
-4
| -2% | -$4.19K |
|
1654
AbCellera Biologics
ABCL
$1.62B
| $287K | ﹤0.01% |
29,483
-10,170
| -26% | -$96.3K |
|
1655
Deluxe
DLX
$1.19B
| $287K | ﹤0.01% |
9,478
-1,055
| -10% | -$33.1K |
|
1656
Liberty Latin America Class C
LILAK
$1.5B
| $287K | ﹤0.01% |
32,901
-5,221
| -14% | -$49.6K |
|
1657
Dine Brands
DIN
$432M
| $286K | ﹤0.01% |
3,655
-446
| -11% | -$33.2K |
|
1658
Fulgent Genetics
FLGT
$559M
| $286K | ﹤0.01% |
4,589
-580
| -11% | -$38.2K |
|
1659
SentinelOne
S
$6.22B
| $286K | ﹤0.01% |
+7,381
| New | +$302K |
|
|
CTEV
1660
Claritev Corp
CTEV
$368M
| $286K | ﹤0.01% |
1,529
-551
| -26% | -$90.7K |
|
1661
PG&E
PCG
$47.8B
| $285K | ﹤0.01% |
23,830
-2,855
| -11% | -$33.8K |
|
1662
Ginkgo Bioworks
DNA
$481M
| $284K | ﹤0.01% |
+1,759
| New | +$342K |
|
1663
Mesa Laboratories
MLAB
$539M
| $284K | ﹤0.01% |
1,114
-133
| -11% | -$36.1K |
|
1664
Sabre
SABR
$656M
| $284K | ﹤0.01% |
24,842
-4,411
| -15% | -$43.2K |
|
1665
US Physical Therapy
USPH
$1.14B
| $284K | ﹤0.01% |
2,848
-350
| -11% | -$33.4K |
|
|
CNR
1666
Core Natural Resources Inc
CNR
$4.19B
| $284K | ﹤0.01% |
+7,528
| New | +$218K |
|
|
XYZ
1667
Block Inc
XYZ
$45.9B
| $284K | ﹤0.01% |
2,099
+130
| +7% | +$15.7K |
|
1668
Elanco Animal Health
ELAN
$12.4B
| $283K | ﹤0.01% |
10,842
-1,068
| -9% | -$28.4K |
|
1669
Stride
LRN
$3.69B
| $283K | ﹤0.01% |
7,780
-1,283
| -14% | -$42.6K |
|
1670
StoneX
SNEX
$8.83B
| $283K | ﹤0.01% |
19,349
-1,878
| -9% | -$26.1K |
|
1671
StepStone Group
STEP
$3.48B
| $283K | ﹤0.01% |
8,574
-257
| -3% | -$8.85K |
|
1672
M/I Homes
MHO
$3.83B
| $282K | ﹤0.01% |
6,379
-772
| -11% | -$39.4K |
|
|
ONEM
1673
DELISTED
1Life Healthcare
ONEM
| $282K | ﹤0.01% |
25,463
-4,269
| -14% | -$47.8K |
|
1674
PJT Partners
PJT
$4.37B
| $281K | ﹤0.01% |
4,446
-735
| -14% | -$47.8K |
|
1675
Kforce
KFRC
$983M
| $280K | ﹤0.01% |
3,796
-636
| -14% | -$45.4K |
|
Similar funds
ProShare Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
- ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
- ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
- ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
- ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
- ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
- ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.
Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.